Latest period
580.70M
YoY change
-2.3%
5Y CAGR
-1.5%
Peak year (2006)
766.80M
Latest annual
585.80M
Shares Outstanding history chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: 585.80M
Shares Outstanding growth chart for Edwards Lifesciences (EW) from 1999 to 2025
Latest: -2.3%
Shares Outstanding history table for Edwards Lifesciences (EW) from 1999 to 2025
| 2025 | 585.80M | -2.3% | -13.50M | ||
| 2024 | 599.30M | -1.7% | -10.10M | ||
| 2023 | 609.40M | -2.4% | -14.80M | ||
| 2022 | 624.20M | -1.1% | -7.00M | ||
| 2021 | 631.20M | -0.1% | -700,000 | ||
| 2020 | 631.90M | -0.7% | -4.70M | ||
| 2019 | 636.60M | -0.7% | -4.20M | ||
| 2018 | 640.80M | -1.1% | -6.90M | ||
| 2017 | 647.70M | -0.9% | -5.70M | ||
| 2016 | 653.40M | -1.1% | -7.50M | ||
| 2015 | 660.90M | +1.5% | +9.90M | ||
| 2014 | 651.00M | -4.7% | -31.80M | ||
| 2013 | 682.80M | -3.8% | -27.00M | ||
| 2012 | 709.80M | -0.9% | -6.60M | ||
| 2011 | 716.40M | +0.2% | +1.20M | ||
| 2010 | 715.20M | +1.5% | +10.80M | ||
| 2009 | 704.40M | -1.5% | -10.80M | ||
| 2008 | 715.20M | -4.9% | -37.20M | ||
| 2007 | 752.40M | -1.9% | -14.40M | ||
| 2006 | 766.80M | +2.6% | +19.20M | ||
| 2005 | 747.60M | +0.5% | +3.60M | ||
| 2004 | 744.00M | +1.5% | +10.80M | ||
| 2003 | 733.20M | -0.3% | -2.40M | ||
| 2002 | 735.60M | +4.1% | +28.80M | ||
| 2001 | 706.80M | +1.4% | +9.73M | ||
| 2000 | 697.07M | 0.0% | 0 | ||
| 1999 | 697.07M | — | — |
- 2025585.80M-2.3%
- 2024599.30M-1.7%
- 2023609.40M-2.4%
- 2022624.20M-1.1%
- 2021631.20M-0.1%
- 2020631.90M-0.7%
- 2019636.60M-0.7%
- 2018640.80M-1.1%
- 2017647.70M-0.9%
- 2016653.40M-1.1%
- 2015660.90M+1.5%
- 2014651.00M-4.7%
- 2013682.80M-3.8%
- 2012709.80M-0.9%
- 2011716.40M+0.2%
- 2010715.20M+1.5%
- 2009704.40M-1.5%
- 2008715.20M-4.9%
- 2007752.40M-1.9%
- 2006766.80M+2.6%
- 2005747.60M+0.5%
- 2004744.00M+1.5%
- 2003733.20M-0.3%
- 2002735.60M+4.1%
- 2001706.80M+1.4%
- 2000697.07M0.0%
- 1999697.07M—
Shares Outstanding values are taken from Edwards Lifesciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported diluted shares outstanding is 580.70M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Edwards Lifesciences (EW) diluted shares outstanding is 585.80M – edged down 2.3% year-over-year.
Edwards Lifesciences diluted shares outstanding has contracted on net over the period, with a -1.5% compound annual growth rate over 2020–2025 (5 years).
Edwards Lifesciences diluted shares outstanding peaked at 766.80M in 2006; the latest annual figure is 585.80M in 2025 (23.6% below peak).
766.80M stands as the all-time-high annual diluted shares outstanding, posted in 2006, against a low of 585.80M during 2025.
Edwards Lifesciences Shares Outstanding by Year
Edwards Lifesciences Shares Outstanding 2025: 585.80M
In 2025, Edwards Lifesciences reported diluted shares outstanding of 585.80M, edged down 2.3% below 2024. This figure represents the lowest annual value in the available history.
Edwards Lifesciences Shares Outstanding 2024: 599.30M
Edwards Lifesciences diluted shares outstanding in 2024 was 599.30M, edged down 1.7% below 2023.
Edwards Lifesciences Shares Outstanding 2023: 609.40M
2023's diluted shares outstanding for Edwards Lifesciences came in at 609.40M, edged down 2.4% below 2022.
Edwards Lifesciences Shares Outstanding 2022: 624.20M
Edwards Lifesciences posted diluted shares outstanding of 624.20M in 2022, edged down 1.1% below 2021.
Edwards Lifesciences Shares Outstanding 2021: 631.20M
Edwards Lifesciences diluted shares outstanding in 2021 was 631.20M.
See more financial history for Edwards Lifesciences (EW).
Sector peers by Shares Outstanding
Healthcare peers of Edwards Lifesciences (EW), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Edwards Lifesciences (EW) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation